Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:

Advisory Board: Boehringer Ingelheim; Cardax; CellProthera; Cereno Scientific; Elsevier Practice Update Cardiology; Janssen; Level Ex; Medscape Cardiology; MyoKardia; NirvaMed; Novo Nordisk; PhaseBio; PLx Pharma; Regado Biosciences; Stasys

Board of Directors: Boston VA Research Institute; Society of Cardiovascular Patient Care; TobeSoft

Chair: Inaugural Chair, American Heart Association Quality Oversight Committee

Data Monitoring Committees: Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott); Boston Scientific (Chair, PEITHO trial); Cleveland Clinic (including for the ExCEED trial, funded by Edwards); Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo); Novartis; Population Health Research Institute

Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Chair, ACC Accreditation Oversight Committee); Arnold and Porter law firm (work related to Sanofi/Bristol Myers Squibb clopidogrel litigation); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring); Belvoir Publications (Editor in Chief, Harvard Heart Letter); Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees); Cowen and Company; Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals); HMP Global (Editor in Chief, Journal of Invasive Cardiology); Journal of the American College of Cardiology (Guest Editor; Associate Editor); K2P (Co-Chair, interdisciplinary curriculum); Level Ex; Medtelligence/ReachMD (CME steering committees); MJH Life Sciences; Piper Sandler; Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer); Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention); Society of Cardiovascular Patient Care (Secretary/Treasurer); WebMD; (CME steering committees)

Other: Clinical Cardiology (Deputy Editor); NCDR-ACTION Registry Steering Committee (Chair); VA CART Research and Publications Committee (Chair)

Research Funding: Abbott; Afimmune; Amarin; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Cardax; CellProthera; Cereno Scientific; Chiesi; CSL Behring; Eisai; Ethicon; Faraday Pharmaceuticals; Ferring Pharmaceuticals; Forest Laboratories; Fractyl; Garmin; HLS Therapeutics; Idorsia; Ironwood; Ischemix; Janssen; Lexicon; Lilly; Medtronic; MyoKardia; NirvaMed; Novartis; Novo Nordisk; Owkin; Pfizer; PhaseBio; PLx Pharma; Regeneron; Roche; Sanofi; Stasys; Synaptic; The Medicines Company; 89Bio

Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease)

Site Co-Investigator: Abbott; Biotronik; Boston Scientific; CSI; Philips; St. Jude Medical (now Abbott); Svelte

Trustee: American College of Cardiology

Unfunded Research: FlowCo; Merck; Takeda

 

George Dangas, MD, PhD, has disclosed the following relevant financial relationships:

Research Funding to Institution:  Abbott Laboratories; AstraZeneca; Bayer; Boston Scientific; Daiichi-Sankyo, Medtronic

 

Gregg Stone, MD, has disclosed the following relevant financial relationships:

Research Funding to Institution:  Abbott

 

Voxmedia:

John F. Kocsis, PhD

President

Hazlet, New Jersey, United States

 

John F. Kocsis, PhD, has disclosed no relevant financial relationships.